HHS regulations
Page 9 of 14
- National Institute of Dental & Craniofacial Research; Notice of MeetingApril 20, 2026
National Institute of Dental & Craniofacial Research announces an upcoming meeting of its advisory council to review research grant applications and program policies.
- Agency Information Collection Activities: Proposed Collection; Comment RequestApril 20, 2026
CMS is seeking public comment for 60 days on proposed information collection activities under the Paperwork Reduction Act of 1995.
- Compliance Policy Regarding Premarket and Other Requirements for Certain NIOSH Approved Air-Purifying Respirators; Draft Guidance for Industry and Food and Drug Administration Staff; AvailabilityApril 20, 2026
FDA issues draft guidance on compliance policies for NIOSH-approved air-purifying respirators including N95s, PAPRs, and reusable respirators to streamline premarket requirements and reduce regulatory burden.
- Establishing Impurity Specifications for Antibiotics; Draft Guidance for Industry; AvailabilityApril 20, 2026
FDA draft guidance establishes impurity specifications for fermentation and semi-synthesis antibiotics in NDAs, ANDAs, and OTC monograph drugs to ensure consistent quality standards.
- Agency Information Collection Activities: Submission for OMB Review; Comment RequestApril 20, 2026
CMS requests public comment under the Paperwork Reduction Act on proposed information collection activities; submit comments by the deadline specified in the Federal Register notice.
- Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Rural Health Network Development Planning Program Performance Improvement and Measurement SystemApril 20, 2026
HRSA's Information Collection Request for the Rural Health Network Development Planning Program measurement system is under OMB review with a 30-day public comment period required before approval.
- Animal Generic Drug User Fee Act; Public Meeting; Request for CommentsApril 17, 2026
The FDA will hold a public meeting to solicit comments on the Animal Generic Drug User Fee Act program and recommendations for its next reauthorization.
- Agency Information Collection Activities: Proposed Collection; Comment RequestApril 17, 2026
Federal agencies request public comment on proposed information collection activities that affect small businesses; submit feedback by the specified deadline to reduce regulatory burden.
- Proposed Information Collection Activity; Personal Responsibility Education Program (PREP) Performance MeasuresApril 17, 2026
ACF's Personal Responsibility Education Program Performance Measures project (OMB #0970-0497) requests continuing data collection from PREP grant recipients through revised participant surveys and reporting forms; OMB approval expires July 31, 2026.
- Agency Information Collection Activities; Proposed Collection; Comment Request; Generic Clearance for Qualitative Data To Support Social and Behavioral Research for Food, Dietary Supplements, Cosmetics, and Animal Food and FeedApril 17, 2026
FDA is accepting public comments for 60 days on a proposed information collection for qualitative social and behavioral research data submissions related to food, dietary supplements, cosmetics, and animal feed.
- Agency Information Collection Activities; Proposed Collection; Comment Request; Radioactive Drug Research CommitteesApril 17, 2026
FDA seeks 60-day public comment on proposed information collection requirements for Radioactive Drug Research Committees governing radioactive drug use in basic research under the Paperwork Reduction Act.
- Authorization of Emergency Use for Four Animal Drugs for the Treatment of New World Screwworm; AvailabilityApril 17, 2026
FDA issues four Emergency Use Authorizations for animal drugs to prevent and treat New World screwworm infestations in cattle, dogs, cats, horses, and other species following HHS's August 18, 2025 public health emergency declaration.
- Animal Drug User Fee Act; Public Meeting; Request for CommentsApril 17, 2026
FDA holds a virtual public meeting to solicit comments on the Animal Drug User Fee Act program and considerations for its next reauthorization.
- Medicaid and Children's Health Insurance Program (CHIP) Generic Information Collection Activities: Proposed Collection; Comment RequestApril 16, 2026
Centers for Medicare and Medicaid Services seeks public comment on generic information collections for Medicaid and CHIP state plan amendments, waivers, demonstrations, and reporting under expedited Paperwork Reduction Act clearance.
- Substance Abuse and Mental Health Services Administration; Agency Information Collection Activities: Proposed Collection; Comment RequestApril 16, 2026
SAMHSA proposes new information collection requirements for substance abuse and mental health services programs; public comment period details available in Federal Register notice.